NPI: 1851959928 · ROANOKE, VA 24014 · Clinical Medical Laboratory · NPI assigned 06/03/2019
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/03/2019 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 16,996 | $28K |
| 2020 | 11,744 | $31K |
| 2021 | 5,548 | $23K |
| 2022 | 5,936 | $23K |
| 2023 | 5,825 | $32K |
| 2024 | 18,411 | $48K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 7,554 | 6,804 | $26K |
| 80061 | Lipid panel | 4,410 | 4,137 | $18K |
| 86803 | 1,609 | 1,525 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,860 | 3,566 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,665 | 3,369 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,800 | 5,058 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,009 | 2,822 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,500 | 3,548 | $8K |
| 87340 | 956 | 911 | $8K | |
| 85027 | 4,120 | 3,576 | $7K | |
| 86762 | 559 | 531 | $4K | |
| 86850 | 1,093 | 1,035 | $4K | |
| 82607 | 843 | 778 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 286 | 241 | $3K |
| 87186 | 1,248 | 1,169 | $3K | |
| 80050 | General health panel | 533 | 471 | $2K |
| 83735 | 1,170 | 1,025 | $2K | |
| 84439 | 705 | 644 | $2K | |
| 86900 | 737 | 699 | $2K | |
| 86901 | 737 | 699 | $2K | |
| 87077 | 941 | 741 | $2K | |
| 82570 | 805 | 755 | $1K | |
| 82728 | 329 | 311 | $1K | |
| 87660 | 217 | 190 | $1K | |
| 87510 | 217 | 190 | $1K | |
| 87480 | 217 | 190 | $1K | |
| 80076 | 358 | 323 | $1K | |
| 83880 | 215 | 195 | $878.60 | |
| 83540 | 386 | 365 | $684.41 | |
| 86140 | 424 | 348 | $666.52 | |
| 82746 | 220 | 198 | $662.63 | |
| 81001 | 1,414 | 1,290 | $605.09 | |
| 87070 | 455 | 426 | $568.48 | |
| 82043 | 512 | 476 | $477.16 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 75 | 71 | $456.17 |
| 87081 | 141 | 136 | $445.49 | |
| 85610 | 584 | 283 | $433.17 | |
| 80074 | 33 | 26 | $423.44 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 74 | 70 | $421.08 |
| 87088 | 226 | 208 | $409.10 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | 19 | $352.00 |
| 85652 | 452 | 381 | $347.85 | |
| 80164 | 223 | 203 | $299.25 | |
| 83550 | 167 | 159 | $281.61 | |
| 83970 | 129 | 123 | $271.97 | |
| 84156 | 167 | 155 | $270.68 | |
| 84550 | 235 | 214 | $265.02 | |
| 86592 | 93 | 93 | $259.16 | |
| 36415 | Collection of venous blood by venipuncture | 6,202 | 4,636 | $238.48 |
| 80348 | 51 | 12 | $237.69 | |
| 82950 | 78 | 67 | $219.40 | |
| 80361 | 29 | 15 | $128.40 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 65 | 65 | $125.56 |
| 84436 | 109 | 87 | $124.33 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 12 | 12 | $121.65 |
| 84480 | 69 | 54 | $121.18 | |
| 86706 | 59 | 53 | $107.40 | |
| 84702 | 37 | 27 | $100.30 | |
| 87205 | 103 | 97 | $86.41 | |
| 80069 | 114 | 104 | $57.21 | |
| 87075 | 41 | 36 | $52.68 | |
| 82105 | 13 | 12 | $50.31 | |
| 87147 | 76 | 72 | $41.44 | |
| 83615 | 24 | 22 | $36.24 | |
| 86160 | 14 | 14 | $35.12 | |
| 84479 | 40 | 33 | $34.48 | |
| 82565 | 22 | 20 | $25.60 | |
| 81003 | 74 | 66 | $21.13 | |
| 84100 | 66 | 52 | $20.55 | |
| 84153 | 55 | 51 | $18.39 | |
| 83690 | 36 | 34 | $13.78 | |
| 82550 | 29 | 24 | $13.02 | |
| 85018 | 26 | 25 | $11.14 | |
| 87045 | 19 | 17 | $3.64 | |
| 87046 | 22 | 17 | $2.02 | |
| 87338 | 15 | 13 | $0.00 | |
| 87177 | 14 | 14 | $0.00 | |
| 85045 | 31 | 28 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13 | 12 | $0.00 |
| 82977 | 18 | 16 | $0.00 | |
| 87899 | 18 | 16 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 131 | 109 | $0.00 |
| 82670 | 13 | 12 | $0.00 |